ELEVANCE HEALTH, INC. (ELV) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Current obligations | 44.25B USD | Liabilities, Current |
| Cash and equivalents | 10.23B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 25.72B USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $44.25B | $10.23B | $25.72B | (m) | (m) | (m) |
| 2026-03-31 | (m) | $45.31B | $9.66B | $25.91B | (m) | (m) | (m) |
| 2025-12-31 | (m) | $41.03B | $9.49B | $25.88B | (m) | (m) | (m) |
| 2025-09-30 | (m) | $40.88B | $8.71B | $26.28B | (m) | (m) | (m) |
| 2025-06-30 | (m) | $43.83B | $8.56B | $25.30B | (m) | (m) | (m) |
| 2025-03-31 | (m) | $42.70B | $7.50B | $25.44B | (m) | (m) | (m) |
| 2024-12-31 | (m) | $40.58B | $8.29B | $25.20B | (m) | (m) | (m) |
| 2024-09-30 | (m) | $42.03B | $7.87B | $28.95B | (m) | (m) | (m) |
| 2024-06-30 | (m) | $41.81B | $6.50B | $28.90B | (m) | (m) | (m) |
| 2024-03-31 | (m) | $44.33B | $6.23B | $29.53B | (m) | (m) | (m) |
| 2023-12-31 | (m) | $41.79B | $6.53B | $29.61B | (m) | (m) | (m) |
| 2023-09-30 | (m) | $43.34B | $10.92B | $27.81B | (m) | (m) | (m) |
| 2023-06-30 | (m) | $41.57B | $9.99B | $28.02B | (m) | (m) | (m) |
| 2023-03-31 | (m) | $41.89B | $10.14B | $27.64B | (m) | (m) | (m) |
| 2022-12-31 | (m) | $39.70B | $7.39B | $25.95B | (m) | (m) | (m) |
| 2022-09-30 | (m) | $41.29B | $8.87B | $25.53B | (m) | (m) | (m) |
| 2022-06-30 | (m) | $39.31B | $6.46B | $25.77B | (m) | (m) | (m) |
| 2022-03-31 | (m) | $39.73B | $6.16B | $26.22B | (m) | (m) | (m) |
| 2021-12-31 | (m) | $34.88B | $4.88B | $26.27B | (m) | (m) | (m) |
| 2021-09-30 | (m) | $35.16B | $5.49B | $26.35B | (m) | (m) | (m) |
| 2021-06-30 | (m) | $33.79B | $5.26B | $25.85B | (m) | (m) | (m) |
| 2021-03-31 | (m) | $34.75B | $9.33B | $24.55B | (m) | (m) | (m) |
| 2020-12-31 | (m) | $29.45B | $5.74B | $23.43B | (m) | (m) | (m) |
| 2020-09-30 | (m) | $28.56B | $3.98B | $22.71B | (m) | (m) | (m) |
| 2020-06-30 | (m) | $28.52B | $6.03B | $22.02B | (m) | (m) | (m) |
| 2020-03-31 | (m) | $27.04B | $5.34B | $19.88B | (m) | (m) | (m) |
| 2019-12-31 | (m) | $23.62B | $4.94B | $19.68B | (m) | (m) | (m) |
| 2019-09-30 | (m) | $23.23B | $4.19B | $19.96B | (m) | (m) | (m) |
| 2019-06-30 | (m) | $23.09B | $4.08B | $19.12B | (m) | (m) | (m) |
| 2019-03-31 | (m) | $22.68B | $4.48B | $17.80B | (m) | (m) | (m) |
| 2018-12-31 | (m) | $21.96B | $3.93B | $16.69B | (m) | (m) | (m) |
| 2018-09-30 | (m) | $24.17B | $4.26B | $17.39B | (m) | (m) | (m) |
| 2018-06-30 | (m) | $24.51B | $4.68B | $17.08B | (m) | (m) | (m) |
| 2018-03-31 | (m) | $24.76B | $4.63B | $17.09B | (m) | (m) | (m) |
| 2017-12-31 | (m) | $23.36B | $3.61B | $17.38B | (m) | (m) | (m) |
| 2017-09-30 | (m) | $24.41B | $6.10B | $18.70B | (m) | (m) | (m) |
| 2017-06-30 | (m) | $22.57B | $4.56B | $18.95B | (m) | (m) | (m) |
| 2017-03-31 | (m) | $23.17B | $6.77B | $17.95B | (m) | (m) | (m) |
| 2016-12-31 | (m) | $21.29B | $4.08B | $17.16B | (m) | (m) | (m) |
| 2016-09-30 | (m) | $21.04B | $2.55B | $18.22B | (m) | (m) | (m) |
| 2016-06-30 | (m) | $20.82B | $1.58B | $18.56B | (m) | (m) | (m) |
| 2016-03-31 | (m) | $20.81B | $1.68B | $18.36B | (m) | (m) | (m) |
| 2015-12-31 | (m) | $19.09B | $2.11B | $16.92B | (m) | (m) | (m) |
| 2015-09-30 | (m) | $18.37B | $1.55B | $17.90B | (m) | (m) | (m) |
| 2015-06-30 | (m) | $20.67B | $1.55B | $18.24B | (m) | (m) | (m) |
| 2015-03-31 | (m) | $21.31B | $1.40B | $18.80B | (m) | (m) | (m) |
| 2014-12-31 | (m) | $18.75B | $2.15B | $17.47B | (m) | (m) | (m) |
| 2014-09-30 | (m) | $18.39B | $1.72B | $18.28B | (m) | (m) | (m) |
| 2014-06-30 | (m) | $19.18B | $1.78B | $18.33B | (m) | (m) | (m) |
| 2014-03-31 | (m) | $18.49B | $1.97B | $18.00B | (m) | (m) | (m) |
| 2013-12-31 | (m) | $16.35B | $1.58B | $17.04B | (m) | (m) | (m) |
| 2013-09-30 | (m) | $16.04B | $2.19B | $17.54B | (m) | (m) | (m) |
| 2013-06-30 | (m) | $16.03B | $1.35B | $17.68B | (m) | (m) | (m) |
| 2013-03-31 | (m) | $16.03B | $1.67B | $17.82B | (m) | (m) | (m) |
| 2012-12-31 | (m) | $15.84B | $2.48B | $16.91B | (m) | (m) | (m) |
| 2012-09-30 | (m) | $14.08B | $2.44B | $18.49B | (m) | (m) | (m) |
| 2012-06-30 | (m) | $16.18B | $1.95B | $17.21B | (m) | (m) | (m) |
| 2012-03-31 | (m) | $15.96B | $2.28B | $16.20B | (m) | (m) | (m) |
| 2011-12-31 | (m) | $15.83B | $2.20B | $15.91B | (m) | (m) | (m) |
| 2011-09-30 | (m) | $15.79B | $2.51B | $16.48B | (m) | (m) | (m) |
| 2011-06-30 | (m) | $14.11B | $1.70B | $16.46B | (m) | (m) | (m) |
| 2011-03-31 | (m) | $14.16B | $2.40B | $15.76B | (m) | (m) | (m) |
| 2010-12-31 | (m) | $14.01B | $1.79B | $16.07B | (m) | (m) | (m) |
| 2010-09-30 | (m) | $14.14B | $2.25B | $16.73B | (m) | (m) | (m) |
| 2010-06-30 | (m) | $14.84B | $2.03B | $15.58B | (m) | (m) | (m) |
| 2010-03-31 | (m) | $14.81B | $3.53B | $15.60B | (m) | (m) | (m) |
| 2009-12-31 | (m) | $14.67B | $4.82B | $15.70B | (m) | (m) | (m) |
| 2009-09-30 | (m) | $14.13B | $1.84B | $15.33B | (m) | (m) | (m) |
| 2009-06-30 | (m) | $14.34B | $1.72B | $14.77B | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | $2.38B | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $15.07B | $2.18B | $1.56B | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | $2.27B | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $2.27B | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $2.77B | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | $2.60B | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |